When Telehealth Isn't Enough: GLP-1 Cases That Need In-Person Medical Care

Telehealth has made GLP-1 access dramatically more convenient, but convenience has limits. Some clinical situations require hands-on evaluation, diagnostic imaging, or in-person intervention that telehealth cannot provide. Knowing when to step outside the telehealth framework — and having a plan to do so — is essential for safe GLP-1 treatment.

Emergency Situations: Go to the ER

These symptoms require immediate in-person emergency evaluation, not a telehealth message:

• Severe abdominal pain radiating to the back — possible pancreatitis. This requires blood work (amylase, lipase) and potentially CT imaging that telehealth cannot provide.
• Right upper quadrant pain with fever — possible cholecystitis (gallbladder inflammation). Ultrasound and blood cultures may be needed.
• Signs of severe dehydration — markedly decreased urine output, confusion, rapid heart rate, inability to keep fluids down for 24+ hours. May require IV fluid resuscitation.
• Severe allergic reaction — anaphylaxis (difficulty breathing, throat swelling, widespread hives) requires epinephrine and emergency stabilization.
• Chest pain or stroke symptoms — while GLP-1 medications reduce cardiovascular risk, they don't eliminate it. Any acute cardiac or neurological symptoms need immediate evaluation.

Complex Cases That Need In-Person Coordination

Beyond emergencies, certain clinical scenarios benefit from or require in-person care:

Patients with multiple comorbidities. If you're managing type 2 diabetes with insulin, heart failure, chronic kidney disease, and obesity simultaneously, the medication interactions and monitoring requirements may exceed what telehealth-only management can safely handle. These patients often benefit from an endocrinologist or obesity medicine specialist who can examine them in person and coordinate with other specialists.

Pre-surgical evaluation. As discussed in anesthesia guidance, patients on GLP-1 medications need specific pre-operative preparation. This typically requires in-person evaluation by the anesthesiology team, potentially including gastric ultrasound to assess stomach contents.

Injection technique problems. If you're experiencing injection site reactions, inconsistent medication absorption, or difficulty with injection technique (particularly with compounded vials requiring self-measured doses), an in-person nursing visit can resolve issues that are difficult to troubleshoot over video.

Suspected thyroid changes. A new neck lump, difficulty swallowing, or persistent hoarseness needs physical examination and potentially thyroid ultrasound — neither of which can be performed through telehealth.

Building a Hybrid Care Model

The most robust GLP-1 treatment approach isn't telehealth-only or in-person-only — it's a hybrid model that uses each modality where it works best:

• Telehealth works for: Routine follow-ups, titration check-ins, side effect management, prescription renewals, lab result reviews, mental health screening, and ongoing coaching.
• In-person works for: Initial comprehensive physical exam (if available), baseline lab draws, suspected acute complications, injection technique training, pre-surgical evaluation, and annual comprehensive health assessments.

If your telehealth platform doesn't acknowledge the existence of situations requiring in-person care, that's a subtler red flag. No platform should position itself as a complete replacement for all healthcare — that's not what telehealth is, even at its best.

What to Tell Your PCP About Your Telehealth GLP-1 Treatment

Many GLP-1 telehealth patients don't inform their primary care provider (PCP) about their treatment. This is a mistake that can have safety consequences:

• Your PCP needs your current medication list for any prescribing decisions they make
• Lab monitoring may be duplicated or missed if your PCP doesn't know about your GLP-1 treatment
• In an emergency, your PCP's records need to reflect your current medications
• Drug interactions can only be evaluated when all prescribers know about all medications